The National Immunisation Schedule was updated in 2020.
From 1 July 2020 the brand of varicella and Hepatitis B vaccine used changed, Tdap replaced ADT vaccine, and the 3-month dose of pneumococcal vaccine was removed. From 1 October 2020 a new event was added at age 12 months so that MMR vaccine is now given at 12 months and 15 months of age, rather than 15 months and 4 years.
The schedule of vaccines listed below applies from 1 October 2020.
Links in the table above provide more information about the diseases and the vaccines that prevent them.
Funded vaccines for high risk groups
Publicly funded hepatitis A, hepatitis B, haemophilus influenzae type b, human papillomavirus, influenza, meningococcal ACWY, pertussis (Tdap), pneumococcal, tuberculosis and varicella vaccines are available for children and adults at high risk of some diseases due to other medical conditions. For more details see the Additional Funded vaccines for special groups page of the Immunisation Handbook.
As part of the schedule change, meningococcal C will only be available for high risk children less than 9 months, with those 9 months and older eligible for meningococcal ACWY.
Immunisation programme decisions
For information about how New Zealand's National Immunisation Schedule is determined and administered, see immunisation programme decisions.